Annual ROE
-52.77%
-17.03%-47.65%
December 31, 2023
Summary
- As of February 7, 2025, SAGE annual return on equity is -52.77%, with the most recent change of -17.03% (-47.65%) on December 31, 2023.
- During the last 3 years, SAGE annual ROE has fallen by -92.95% (-231.33%).
- SAGE annual ROE is now -173.38% below its all-time high of 71.91%, reached on December 31, 2012.
Performance
SAGE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-48.20%
+8.44%+14.90%
September 30, 2024
Summary
- As of February 7, 2025, SAGE quarterly return on equity is -48.20%, with the most recent change of +8.44% (+14.90%) on September 30, 2024.
- Over the past year, SAGE quarterly ROE has increased by +8.44% (+14.90%).
- SAGE quarterly ROE is now -116.40% below its all-time high of 293.97%, reached on June 30, 2014.
Performance
SAGE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SAGE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.6% | +14.9% |
| 3 y3 years | -231.3% | -227.7% |
| 5 y5 years | +5.3% | +21.5% |
SAGE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -119.0% | at low | -101.5% | +18.2% |
| 5 y | 5-year | -231.3% | +29.9% | -183.7% | +24.1% |
| alltime | all time | -173.4% | +29.9% | -116.4% | +74.2% |
Sage Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -48.20%(-14.9%) |
| Jun 2024 | - | -56.64%(-0.1%) |
| Mar 2024 | - | -56.67%(+4.4%) |
| Dec 2023 | -52.77%(+47.6%) | -54.30%(-7.8%) |
| Sep 2023 | - | -58.91%(+24.5%) |
| Jun 2023 | - | -47.30%(+16.9%) |
| Mar 2023 | - | -40.47%(+13.7%) |
| Dec 2022 | -35.74%(+48.4%) | -35.59%(+12.5%) |
| Sep 2022 | - | -31.63%(+8.3%) |
| Jun 2022 | - | -29.20%(+9.9%) |
| Mar 2022 | - | -26.56%(+11.0%) |
| Dec 2021 | -24.09%(-160.0%) | -23.92%(-163.3%) |
| Sep 2021 | - | 37.76%(-16.1%) |
| Jun 2021 | - | 44.99%(-10.7%) |
| Mar 2021 | - | 50.38%(-12.5%) |
| Dec 2020 | 40.18%(-153.4%) | 57.57%(-191.5%) |
| Sep 2020 | - | -62.90%(-0.9%) |
| Jun 2020 | - | -63.48%(+6.5%) |
| Mar 2020 | - | -59.62%(-5.2%) |
| Dec 2019 | -75.26% | -62.86%(+2.4%) |
| Sep 2019 | - | -61.41%(+9.2%) |
| Jun 2019 | - | -56.22%(+29.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -43.49%(+16.3%) |
| Dec 2018 | -55.72%(-1.9%) | -37.40%(+18.6%) |
| Sep 2018 | - | -31.54%(-5.5%) |
| Jun 2018 | - | -33.38%(-42.2%) |
| Mar 2018 | - | -57.73%(-33.0%) |
| Dec 2017 | -56.81%(+31.7%) | -86.14%(-3.7%) |
| Sep 2017 | - | -89.46%(+37.9%) |
| Jun 2017 | - | -64.86%(+18.9%) |
| Mar 2017 | - | -54.56%(+13.8%) |
| Dec 2016 | -43.14%(-20.7%) | -47.93%(+3.1%) |
| Sep 2016 | - | -46.51%(-9.6%) |
| Jun 2016 | - | -51.45%(+4.3%) |
| Mar 2016 | - | -49.35%(-9.2%) |
| Dec 2015 | -54.40%(+96.1%) | -54.33%(+11.7%) |
| Sep 2015 | - | -48.63%(+10.4%) |
| Jun 2015 | - | -44.04%(-22.4%) |
| Mar 2015 | - | -56.73%(+10.6%) |
| Dec 2014 | -27.74%(-147.9%) | -51.29%(-48.0%) |
| Sep 2014 | - | -98.57%(-133.5%) |
| Jun 2014 | - | 293.97%(-257.2%) |
| Mar 2014 | - | -187.02%(-422.6%) |
| Dec 2013 | 57.97%(-19.4%) | 57.97% |
| Dec 2012 | 71.91% | - |
FAQ
- What is Sage Therapeutics annual return on equity?
- What is the all time high annual ROE for Sage Therapeutics?
- What is Sage Therapeutics annual ROE year-on-year change?
- What is Sage Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Sage Therapeutics?
- What is Sage Therapeutics quarterly ROE year-on-year change?
What is Sage Therapeutics annual return on equity?
The current annual ROE of SAGE is -52.77%
What is the all time high annual ROE for Sage Therapeutics?
Sage Therapeutics all-time high annual return on equity is 71.91%
What is Sage Therapeutics annual ROE year-on-year change?
Over the past year, SAGE annual return on equity has changed by -17.03% (-47.65%)
What is Sage Therapeutics quarterly return on equity?
The current quarterly ROE of SAGE is -48.20%
What is the all time high quarterly ROE for Sage Therapeutics?
Sage Therapeutics all-time high quarterly return on equity is 293.97%
What is Sage Therapeutics quarterly ROE year-on-year change?
Over the past year, SAGE quarterly return on equity has changed by +8.44% (+14.90%)